Kirkland

Paul T. Cappuccio Joins Leadership of Torridon Law PLLC

Retrieved on: 
月曜日, 5月 6, 2024

WASHINGTON, May 6, 2024 /PRNewswire/ -- Today Torridon Law PLLC announced that Paul T. Cappuccio has joined the firm as a partner and member of the firm's management committee.

Key Points: 
  • WASHINGTON, May 6, 2024 /PRNewswire/ -- Today Torridon Law PLLC announced that Paul T. Cappuccio has joined the firm as a partner and member of the firm's management committee.
  • During his time in-house, he has overseen hundreds of billions of dollars of complex corporate transactions, and related antitrust and regulatory reviews.
  • Mr. Cappuccio will work out of a new Torridon Law PLLC office in New York.
  • Torridon Law is committed to upholding the values, collegiality, and client-focused ethos that traditionally have distinguished the law as a profession.

Genesys Works Announces Five New National Board Members, Including Program Graduate

Retrieved on: 
水曜日, 5月 1, 2024

HOUSTON, May 1, 2024 /PRNewswire/ -- Genesys Works, a national youth career readiness program for students in underserved communities, announced today five new members of its National Board of Directors.

Key Points: 
  • Board members to drive Genesys Works' strategic growth plan, significantly extending the program's reach and impact.
  • They will help drive Genesys Works' strategic growth plan, significantly extending the program's reach and impact.
  • Over the next five years, Genesys Works will triple the number of students served in existing and new markets.
  • "Our new board members will broaden our National Board's depth of expertise in several key industries and skill areas, including entrepreneurship, risk and compliance, fund development, and human capital management," said Jeffrey Artis, Genesys Works President and CEO.

EQS-News: GREENPEAK Partners closes inaugural Continuation Fund led by HarbourVest Partners for two leading Germany-based companies in the specialty laboratories and Testing, Inspection, and Certification (‘TIC

Retrieved on: 
金曜日, 5月 3, 2024

GREENPEAK Partners closes inaugural Continuation Fund led by HarbourVest Partners for two leading Germany-based companies in the specialty laboratories and Testing, Inspection, and Certification (‘TIC

Key Points: 
  • GREENPEAK Partners closes inaugural Continuation Fund led by HarbourVest Partners for two leading Germany-based companies in the specialty laboratories and Testing, Inspection, and Certification (‘TIC
    The issuer is solely responsible for the content of this announcement.
  • GREENPEAK Partners closes inaugural Continuation Fund led by HarbourVest Partners for two leading Germany-based companies in the specialty laboratories and Testing, Inspection, and Certification (‘TIC’) spaces
    MUNICH, 16th April, 2024 – GREENPEAK Partners, a leading lower mid-market focused buy and build specialist in the DACH region, is pleased to announce the successful close of GREENPEAK Continuation              Fund I with total commitments of ca.
  • Continuation Fund I was formed to invest into ACADEMIA and CERTANIA – two strongly performing lab and TIC groups started and built up by funds managed by GREENPEAK Fund II GmbH & Co. KG (“GREENPEAK Fund II”) in 2021.
  • Investors in Continuation Fund I will also provide additional capital to enable GREENPEAK to continue its successful growth strategies in both companies.

Norton Rose Fulbright continues Chicago growth with investment funds partner

Retrieved on: 
月曜日, 4月 22, 2024

Chicago, IL, April 22, 2024 (GLOBE NEWSWIRE) -- Global law firm Norton Rose Fulbright announced today that investment funds lawyer Joshua Cohen has joined the firm in the Chicago office as a partner.

Key Points: 
  • Chicago, IL, April 22, 2024 (GLOBE NEWSWIRE) -- Global law firm Norton Rose Fulbright announced today that investment funds lawyer Joshua Cohen has joined the firm in the Chicago office as a partner.
  • Cohen advises clients in the formation, structuring and maintenance of open and closed-end private funds, including hedge funds, private equity and credit funds, hybrid funds, fund of funds vehicles, liquid alternative mutual funds and scalable platforms for fund sponsors.
  • Jeff Cody, Norton Rose Fulbright’s US Managing Partner, said:
    “Josh is an excellent addition to our investment funds group with valuable in-house and asset management experience that our clients will appreciate.
  • Norton Rose Fulbright provides a full scope of legal services to the world’s preeminent corporations and financial institutions.

Nebraska Court Decides in Favour of Farmers Edge

Retrieved on: 
金曜日, 4月 12, 2024

Farmers Edge Inc. (“Farmers Edge” or the “Company”), a pure-play digital agriculture company, is pleased to announce that the United States District Court for the District of Nebraska has ruled in favour of Farmers Edge in a patent infringement suit brought by AGI SureTrack, LLC (formerly Farmobile, LLC) (“AGI”).

Key Points: 
  • Farmers Edge Inc. (“Farmers Edge” or the “Company”), a pure-play digital agriculture company, is pleased to announce that the United States District Court for the District of Nebraska has ruled in favour of Farmers Edge in a patent infringement suit brought by AGI SureTrack, LLC (formerly Farmobile, LLC) (“AGI”).
  • The court ruled that five patents asserted by AGI purporting to relate to precision agriculture technology are invalid.
  • This decision reflects Farmers Edge’s unwavering dedication to defending its innovation and the integrity of its process.
  • Farmers Edge was represented by Kirkland & Ellis LLP.

Invitae Enters into Agreement with Labcorp for Sale of Business

Retrieved on: 
木曜日, 4月 25, 2024

SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- Invitae (OTC:NVTA), a leading medical genetics company, announced that Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has been selected as the winning bidder in the Company's auction in its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp will acquire substantially all of the Company's assets on a going concern basis for $239 million in cash consideration, plus other non-cash consideration.

Key Points: 
  • Labcorp will acquire substantially all of the Company's assets on a going concern basis for $239 million in cash consideration, plus other non-cash consideration.
  • "The agreement with Labcorp marks a significant step in our financial restructuring and supports our efforts to continue to deliver innovative and industry leading products and services for healthcare," said Ken Knight, president and chief executive officer of Invitae.
  • The hearing to approve the sale is currently scheduled for May 6, 2024.
  • With Court approval, as well as customary regulatory approvals and closing conditions, Labcorp and Invitae anticipate completing the sale process in the third quarter of 2024.

Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction

Retrieved on: 
火曜日, 4月 2, 2024

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (“Sientra” or the “Company”) announced that, following the completion of its Section 363 sales auction, Tiger Aesthetics Medical, LLC (“Tiger”) has been declared the successful bidder for certain of the assets of Sientra used in its breast reconstruction and augmentation business. As consideration for the acquisition, Tiger will pay a cash consideration of $42.5 million as well as assume certain liabilities of the Company, including up to $7 million in cure costs for certain assumed contracts, all the Company’s warranties for breast implants sold prior to the closing date, and all of the Company’s customer contracts.

Key Points: 
  • IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (“Sientra” or the “Company”) announced that, following the completion of its Section 363 sales auction, Tiger Aesthetics Medical, LLC (“Tiger”) has been declared the successful bidder for certain of the assets of Sientra used in its breast reconstruction and augmentation business.
  • Sientra also announced that it has entered into a definitive agreement with Nuance Intermediary, LLC (“Nuance”), pursuant to which Nuance will acquire substantially all the assets of Sientra used in its BIOCORNEUM business.
  • Tiger Aesthetics Medical, LLC is represented by Blank Rome LLP as legal counsel and H.C. Wainwright & Co. as investment banker.
  • Nuance Intermediary, LLC, an investment of Nuance Holdings LLC, as well as the owner of Nuance Medical, is represented by Ferguson Braswell Fraser Kubasta PC as legal counsel.

National Philanthropic Trust Names Linda K. Myers Chair of the Board of Trustees

Retrieved on: 
火曜日, 4月 9, 2024

National Philanthropic Trust (NPT), the largest national, independent public charity that manages donor-advised funds (DAFs), and one of the largest grantmaking organizations in the world, is pleased to announce Linda K. Myers has been named chair of NPT’s Board of Trustees.

Key Points: 
  • National Philanthropic Trust (NPT), the largest national, independent public charity that manages donor-advised funds (DAFs), and one of the largest grantmaking organizations in the world, is pleased to announce Linda K. Myers has been named chair of NPT’s Board of Trustees.
  • She has served as vice chair of NPT’s Board of Trustees and chair of the Compensation and Human Resources Committee.
  • “Linda’s extensive experience in law, business, and governance, along with her lifelong dedication to philanthropy, is an excellent foundation for her to be NPT’s board chair,” said Eileen Heisman, CEO of National Philanthropic Trust.
  • “Linda joined NPT’s Board of Trustees in the early days of the pandemic and quickly became a strategic voice on the board and in her committee leadership.

Mesirow Names Ketan Shah to Newly Created Chief Strategy Officer Role, Reinforcing Focus on Growth Initiatives

Retrieved on: 
月曜日, 4月 8, 2024

Shah to partner with CEO, Board of Directors and executive leadership team

Key Points: 
  • Shah to partner with CEO, Board of Directors and executive leadership team
    CHICAGO, April 8, 2024 /PRNewswire/ -- Mesirow, an independent, employee-owned financial services firm, today announced the promotion of Ketan Shah to Chief Strategy Officer.
  • In this newly created role, Shah will partner closely with Mesirow's CEO, Board of Directors and leadership team to develop and implement the firm's strategic growth plans.
  • In addition to serving as Chief Strategy Officer, Shah will continue with his existing responsibilities as the firm's General Counsel and will continue to report to Natalie Brown, Mesirow's CEO.
  • "Ketan's promotion to Chief Strategy Officer is a testament to his outstanding contributions and deep understanding of our business," said Natalie Brown , Mesirow CEO.

ProAmpac to Acquire Gelpac From an Investor Group Led by Namakor, and Supported by W Investments

Retrieved on: 
水曜日, 3月 13, 2024

ProAmpac , a global leader in flexible packaging and material science, and Gelpac , a premier producer of multiwall paper and poly-woven packaging products, today announced the signing of a definitive agreement under which ProAmpac will acquire Gelpac from an investor group led by NAMAKOR Holdings (“NAMAKOR”), including Groupe W Investissements (“W Investments”) and CDPQ.

Key Points: 
  • ProAmpac , a global leader in flexible packaging and material science, and Gelpac , a premier producer of multiwall paper and poly-woven packaging products, today announced the signing of a definitive agreement under which ProAmpac will acquire Gelpac from an investor group led by NAMAKOR Holdings (“NAMAKOR”), including Groupe W Investissements (“W Investments”) and CDPQ.
  • Combining Gelpac and ProAmpac will allow the company to better serve customers in the high-growth food and beverage, agriculture, industrial and pharmaceutical end markets.
  • “Gelpac shares ProAmpac’s commitment to serve customers across the U.S. and Canada with high-performance, sustainability-focused flexible packaging solutions,” said Greg Tucker, Founder, Vice Chairman and Chief Executive Officer of ProAmpac.
  • Gelpac was represented by Fasken Martineau DuMoulin L.L.P and Bradley L.L.P and Mesirow served as the exclusive sell-side advisor to Gelpac.